CLEARPOINT NEURO INC. - COMMON STOCK
11.35
19-9月-25 07:50:59
15 分の遅延
株式
0.00
0.00%
本日の幅
11.23 - 11.54
ISIN
N/A
ソース
NASDAQ
-
ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
22 1 2024 13:05:00 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
16 1 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
08 1 2024 13:05:00 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Third Quarter 2023 Results
09 11 2023 13:05:01 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023
26 10 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Second Quarter 2023 Results
08 8 2023 13:05:01 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023
25 7 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
24 5 2023 06:25:00 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference
18 5 2023 13:01:00 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports First Quarter 2023 Results
11 5 2023 13:05:01 提供 Nasdaq GlobeNewswire
-
10 5 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023
28 4 2023 13:42:12 提供 Nasdaq GlobeNewswire
-
20 4 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
18 4 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil
13 4 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
11 4 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
28 3 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results
01 3 2023 13:05:01 提供 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2022 Revenue Results March 1, 2023
15 2 2023 13:05:00 提供 Nasdaq GlobeNewswire
-
11 1 2023 05:00:00 提供 Nasdaq GlobeNewswire